Literature DB >> 7581951

Physiological concentrations of retinoic acid suppress the osteoblastic differentiation of fetal rat calvaria cells in vitro.

K Ohishi1, S Nishikawa, T Nagata, N Yamauchi, H Shinohara, J Kido, H Ishida.   

Abstract

The effects of retinoic acid (RA) on osteoblastic differentiation and activity were studied in fetal rat calvaria cells cultured for up to 24 days. Fetal bovine serum used for the experiments was treated with an anion-exchange resin to remove endogenous RA. The depletion of RA in the treated serum was confirmed by high-performance liquid chromatography and tritiated RA tracing. Under the culture conditions employed, the continuous presence of RA for 14 days at 10(-9) mol/l or higher decreased both alkaline phosphatase (ALP) activity on day 12 and the number of bone nodules on day 14 in a dose-dependent manner. Short-term (24 h) exposure to RA at 10(-8) mol/l, which is a physiological concentration, decreased and increased the levels of ALP and osteopontin mRNA on day 6, respectively. Retinoic acid at 10(-8) mol/l also increased the level of osteocalcin mRNA on day 12. However, these effects were not obvious at later stages (days 18 and 24). At a high concentration (10(-6) mol/l), RA increased the level of osteopontin mRNA on day 6 and decreased the levels of ALP and osteocalcin mRNA irrespective of culture period. These results suggest that, at physiological concentrations, RA suppresses the differentiation of osteoprogenitor cells and regulates osteoblastic functions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7581951     DOI: 10.1530/eje.0.1330335

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  10 in total

1.  Progesterone-mediated stimulation of osteoprogenitor proliferation and differentiation in cell populations derived from adult or fetal rat bone tissue depends on the serum component of the culture media.

Authors:  Y Ishida; C G Bellows; I Tertinegg; J N Heersche
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  Effect of retinoic acid and vitamin D3 on osteoblast differentiation and activity in aging.

Authors:  Michela Bosetti; Maurizio Sabbatini; Anna Calarco; Alessia Borrone; Gianfranco Peluso; Mario Cannas
Journal:  J Bone Miner Metab       Date:  2015-02-18       Impact factor: 2.626

3.  Immediate effects of retinoic acid on gene expression in primary murine osteoblasts.

Authors:  Timur A Yorgan; Timo Heckt; Carsten Rendenbach; Christina Helmis; Sebastian Seitz; Thomas Streichert; Michael Amling; Thorsten Schinke
Journal:  J Bone Miner Metab       Date:  2015-05-09       Impact factor: 2.626

4.  Regulation of neural crest cell fate by the retinoic acid and Pparg signalling pathways.

Authors:  Nan Li; Robert N Kelsh; Peter Croucher; Henry H Roehl
Journal:  Development       Date:  2010-02       Impact factor: 6.868

5.  Restriction of retinoic acid activity by Cyp26b1 is required for proper timing and patterning of osteogenesis during zebrafish development.

Authors:  Kathrin Laue; Martina Jänicke; Nikki Plaster; Carmen Sonntag; Matthias Hammerschmidt
Journal:  Development       Date:  2008-10-16       Impact factor: 6.868

6.  Retinoic and ascorbic acids induce osteoblast differentiation from human dental pulp mesenchymal stem cells.

Authors:  Lina M Escobar; José Daniel Escobar; Zita Bendahan; Jaime E Castellanos
Journal:  J Oral Biol Craniofac Res       Date:  2021-01-13

Review 7.  Retinoid receptors in bone and their role in bone remodeling.

Authors:  Petra Henning; H Herschel Conaway; Ulf H Lerner
Journal:  Front Endocrinol (Lausanne)       Date:  2015-03-11       Impact factor: 5.555

8.  The role of Zic transcription factors in regulating hindbrain retinoic acid signaling.

Authors:  Danna L Drummond; Caroline S Cheng; Lyndsay G Selland; Jennifer C Hocking; Lisa B Prichard; Andrew J Waskiewicz
Journal:  BMC Dev Biol       Date:  2013-08-12       Impact factor: 1.978

9.  Vitamin a is a negative regulator of osteoblast mineralization.

Authors:  Thomas Lind; Anders Sundqvist; Lijuan Hu; Gunnar Pejler; Göran Andersson; Annica Jacobson; Håkan Melhus
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

10.  All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia.

Authors:  Chi Huu Nguyen; Katharina Bauer; Hubert Hackl; Angela Schlerka; Elisabeth Koller; Anastasiya Hladik; Dagmar Stoiber; Johannes Zuber; Philipp B Staber; Andrea Hoelbl-Kovacic; Louise E Purton; Florian Grebien; Rotraud Wieser
Journal:  Cell Death Dis       Date:  2019-12-10       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.